{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:09:09Z","timestamp":1778875749080,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s11606-019-05266-2","type":"journal-article","created":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T23:09:03Z","timestamp":1565824143000},"page":"2643-2647","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cardiovascular Risk Heterogeneity in Adults with Diabetes: Selective Use of Coronary Artery Calcium in Statin Use Decision-making"],"prefix":"10.1007","volume":"34","author":[{"given":"Sudipa","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olusola A.","family":"Orimoloye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin M.","family":"Nass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger S.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth S.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,14]]},"reference":[{"issue":"Suppl 2","key":"5266_CR1","doi-asserted-by":"publisher","first-page":"S384","DOI":"10.2337\/dc09-S345","volume":"32","author":"R Eldor","year":"2009","unstructured":"Eldor R, Raz I. American Diabetes Association indications for statins in diabetes: is there evidence?, Diabetes Care. 2009;32 Suppl 2:S384\u201391.","journal-title":"Diabetes Care."},{"key":"5266_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"SM Haffner","year":"1998","unstructured":"Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229\u201334.","journal-title":"N Engl J Med."},{"key":"5266_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1464-5491.2008.02640.x","volume":"26","author":"U Bulugahapitiya","year":"2009","unstructured":"Bulugahapitiya U, Siyambalapitiya S, Sithole J, Idris I. Is diabetes a coronary risk equivalent? Systematic review and meta-analysis. Diabet Med. 2009;26:142\u20138.","journal-title":"Diabet Med."},{"key":"5266_CR4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1136\/bmj.324.7343.939","volume":"324","author":"JM Evans","year":"2002","unstructured":"Evans JM, Wang J, Morris AD. Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ. 2002;324:939\u201342.","journal-title":"BMJ."},{"key":"5266_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11606-015-3556-3","volume":"31","author":"JS Rana","year":"2016","unstructured":"Rana JS, Liu JY, Moffet HH, Jaffe M, Karter AJ. Diabetes and prior coronary heart disease are not necessarily risk equivalent for future coronary heart disease events. J Gen Intern Med. 2016;31:387\u201393.","journal-title":"J Gen Intern Med."},{"key":"5266_CR6","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.2337\/dc19-S010","volume":"42","author":"American Diabetes Association","year":"2019","unstructured":"American Diabetes Association. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42:S103-S23.","journal-title":"Diabetes Care."},{"key":"5266_CR7","unstructured":"Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019."},{"key":"5266_CR8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s11886-015-0607-7","volume":"17","author":"MO Gore","year":"2015","unstructured":"Gore MO, McGuire DK, Lingvay I, Rosenstock J. Predicting cardiovascular risk in type 2 diabetes: the heterogeneity challenges. Curr Cardiol Rep. 2015;17:607.","journal-title":"Curr Cardiol Rep."},{"key":"5266_CR9","unstructured":"Mirbolouk M, Blaha M. The asymptomatic patient: risk factor score or calcium score?"},{"key":"5266_CR10","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1001\/jamacardio.2017.4191","volume":"2","author":"S Malik","year":"2017","unstructured":"Malik S, Zhao Y, Budoff M, et al. Coronary artery calcium score for long-term risk classification in individuals with type 2 diabetes and metabolic syndrome from the multi-ethnic study of atherosclerosis. JAMA Cardiol. 2017;2:1332\u201340.","journal-title":"JAMA Cardiol."},{"key":"5266_CR11","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1056\/NEJMoa072100","volume":"358","author":"R Detrano","year":"2008","unstructured":"Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358:1336\u201345.","journal-title":"N Engl J Med."},{"key":"5266_CR12","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jacc.2010.06.030","volume":"56","author":"R Erbel","year":"2010","unstructured":"Erbel R, Mohlenkamp S, Moebus S, et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol. 2010;56:1397\u2013406.","journal-title":"J Am Coll Cardiol."},{"key":"5266_CR13","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.amjcard.2012.01.358","volume":"109","author":"JS Rana","year":"2012","unstructured":"Rana JS, Gransar H, Wong ND, et al. Comparative value of coronary artery calcium and multiple blood biomarkers for prognostication of cardiovascular events. Am J Cardiol. 2012;109:1449\u201353.","journal-title":"Am J Cardiol."},{"key":"5266_CR14","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1001\/jama.2010.461","volume":"303","author":"TS Polonsky","year":"2010","unstructured":"Polonsky TS, McClelland RL, Jorgensen NW, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010;303:1610\u20136.","journal-title":"JAMA."},{"key":"5266_CR15","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1161\/CIRCULATIONAHA.115.018524","volume":"133","author":"MJ Blaha","year":"2016","unstructured":"Blaha MJ, Cainzos-Achirica M, Greenland P, et al. Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2016;133:849\u201358.","journal-title":"Circulation."},{"key":"5266_CR16","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1093\/eurheartj\/eht508","volume":"35","author":"MG Silverman","year":"2014","unstructured":"Silverman MG, Blaha MJ, Krumholz HM, et al. Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosclerosis. Eur Heart J. 2014;35:2232\u201341.","journal-title":"Eur Heart J."},{"key":"5266_CR17","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.jacc.2015.07.066","volume":"66","author":"K Nasir","year":"2015","unstructured":"Nasir K, Bittencourt MS, Blaha MJ, et al. Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology\/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2015;66:1657\u201368.","journal-title":"J Am Coll Cardiol."},{"key":"5266_CR18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jcmg.2008.12.031","volume":"2","author":"A Sarwar","year":"2009","unstructured":"Sarwar A, Shaw LJ, Shapiro MD, et al. Diagnostic and prognostic value of absence of coronary artery calcification. JACC Cardiovasc Imaging. 2009;2:675\u201388.","journal-title":"JACC Cardiovasc Imaging."},{"key":"5266_CR19","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jcmg.2017.04.016","volume":"10","author":"PH Joshi","year":"2017","unstructured":"Joshi PH, Blaha MJ, Budoff MJ, et al. The 10-year prognostic value of zero and minimal CAC. JACC Cardiovasc Imaging. 2017;10:957\u20138.","journal-title":"JACC Cardiovasc Imaging."},{"key":"5266_CR20","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","volume":"129","author":"DC Goff Jr","year":"2014","unstructured":"Goff DC Jr., Lloyd-Jones DM, Bennett G, et al. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S49\u201373.","journal-title":"Circulation."},{"key":"5266_CR21","unstructured":"Elkeles RS, Godsland IF, Michael D, et al. Coronary Calcium Measurement Improves Prediction of Cardiovascular Events in Asymptomatic Patients With Type 2 Diabetes: The PREDICT Study. MJ Budoff. Eur Heart J 2008;18:2193\u20134."},{"issue":"6","key":"5266_CR22","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/eurheartj\/ehi808","volume":"27","author":"Dhakshinamurthy Vijay Anand","year":"2006","unstructured":"Anand DV, Lim E, Hopkins D, et al. Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J. 2006;6:713\u201321.","journal-title":"European Heart Journal"},{"key":"5266_CR23","unstructured":"Silverman MG, Blaha MJ, Budoff M, et al. Coronary artery calcium and cardiovascular events in diabetes: implications for primary prevention therapies: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2018;126."},{"key":"5266_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3803\/EnM.2017.32.1.47","volume":"32","author":"R Blankstein","year":"2017","unstructured":"Blankstein R, Gupta A, Rana JS, Nasir K. The implication of coronary artery calcium testing for cardiovascular disease prevention and diabetes. Endocrinol Metab (Seoul). 2017;32:47\u201357.","journal-title":"Endocrinol Metab (Seoul)."},{"key":"5266_CR25","doi-asserted-by":"crossref","unstructured":"Dahagam C HV, Goud A, D\u2019Souza J, Abdelqader A, Blumenthal RS, Martin SS. Role of statins in glucose homeostasis and insulin resistance. Curr Atheroscler Rep. 2016;10.","DOI":"10.1007\/s12170-016-0523-4"},{"key":"5266_CR26","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1007\/s00125-014-3374-x","volume":"57","author":"S Erqou","year":"2014","unstructured":"Erqou S, Lee CC, Adler AI. Statins and glycaemic control in individuals with diabetes: a systematic review and meta-analysis. Diabetologia. 2014;57:2444\u201352.","journal-title":"Diabetologia."},{"key":"5266_CR27","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1517\/14656561003641990","volume":"11","author":"T Teramoto","year":"2010","unstructured":"Teramoto T, Shimano H, Yokote K, Urashima M. New evidence on pitavastatin: efficacy and safety in clinical studies. Expert Opin Pharmacother. 2010;11:817\u201328.","journal-title":"Expert Opin Pharmacother."},{"key":"5266_CR28","doi-asserted-by":"crossref","unstructured":"Kambhampati S, Ashvetiya T, Stone NJ, Blumenthal RS, Martin SS. Shared decision-making and patient empowerment in preventive cardiology. Curr Cardiol Rep. 2016;18.","DOI":"10.1007\/s11886-016-0729-6"},{"key":"5266_CR29","doi-asserted-by":"crossref","unstructured":"Spatz ES, Montori VM. Primary prevention with statins: strategies to support shared decision-making. Curr Cardiovasc Risk Rep. 2017;11.","DOI":"10.1007\/s12170-017-0556-3"},{"key":"5266_CR30","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1345\/aph.1K209","volume":"41","author":"B McGinnis","year":"2007","unstructured":"McGinnis B, Olson KL, Magid D, et al. Factors related to adherence to statin therapy. Ann Pharmacother. 2007;41:1805\u201311.","journal-title":"Ann Pharmacother."},{"key":"5266_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12875-016-0436-9","volume":"17","author":"B Barrett","year":"2016","unstructured":"Barrett B, Ricco J, Wallace M, Kiefer D, Rakel D. Communicating statin evidence to support shared decision-making. BMC Fam Pract. 2016;17:41.","journal-title":"BMC Fam Pract."},{"key":"5266_CR32","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/j.jdiacomp.2016.04.021","volume":"30","author":"S Kianoush","year":"2016","unstructured":"Kianoush S, Al Rifai M, Whelton SP, et al. Stratifying cardiovascular risk in diabetes: The role of diabetes-related clinical characteristics and imaging. J Diabetes Complicat. 2016;30:1408\u201315.","journal-title":"J Diabetes Complicat."},{"key":"5266_CR33","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jcmg.2017.04.014","volume":"10","author":"JC Hong","year":"2017","unstructured":"Hong JC, Blankstein R, Shaw LJ, et al. Implications of coronary artery calcium testing for treatment decisions among statin candidates according to the ACC\/AHA Cholesterol Management Guidelines: A Cost-Effectiveness Analysis. JACC Cardiovasc Imaging. 2017;10:938\u201352.","journal-title":"JACC Cardiovasc Imaging."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-019-05266-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-019-05266-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-019-05266-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:10:42Z","timestamp":1597363842000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-019-05266-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,14]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["5266"],"URL":"https:\/\/doi.org\/10.1007\/s11606-019-05266-2","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,14]]},"assertion":[{"value":"1 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"SSM has no disclosures specifically related to coronary artery calcium imaging. He has received personal fees for serving on scientific advisory boards for Amgen, Sanofi\/Regeneron, Quest Diagnostics, Esperion, Akcea Therapeutics, and Novo Nordisk. He reports grants\/research support from the NIH, PJ Schafer Cardiovascular Research Fund, the David and June Trone Family Foundation, American Heart Association, Aetna Foundation, Maryland Innovation Initiative, Nokia, Google, and Apple; in addition, he is listed as a co-inventor on a patent application pending on a method of LDL-C estimation. All remaining authors declare that they do not have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}